These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 950324)

  • 21. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
    Aswapokee N; Neu HC
    J Antibiot (Tokyo); 1978 Dec; 31(12):1238-44. PubMed ID: 310815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Lactamase inhibitors--a novel approach.
    Lancet; 1979 Sep; 2(8142):565-6. PubMed ID: 89565
    [No Abstract]   [Full Text] [Related]  

  • 23. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():103-10. PubMed ID: 6976960
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibacterial activity of a monocyclic beta-lactam SQ 26,776.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():111-22. PubMed ID: 6799479
    [No Abstract]   [Full Text] [Related]  

  • 26. The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds.
    Romagnoli MF; Fu KP; Neu HC
    J Antimicrob Chemother; 1980 Sep; 6(5):601-6. PubMed ID: 6967870
    [No Abstract]   [Full Text] [Related]  

  • 27. The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
    Wise R; Gillett AP; Andrews JM
    J Antimicrob Chemother; 1979 May; 5(3):301-6. PubMed ID: 113377
    [No Abstract]   [Full Text] [Related]  

  • 28. The inhibition of bacterial beta-lactamases by some monocyclic beta-lactams.
    Isaacs NS; Sunman G; Reading C
    J Antibiot (Tokyo); 1982 May; 35(5):589-93. PubMed ID: 6980873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 30. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects for expanding the use of beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1992 Nov; 37(5):297-8. PubMed ID: 1433250
    [No Abstract]   [Full Text] [Related]  

  • 32. A new olivanic acid derivative produced by Streptomyces olivaceus: isolation and structural studies.
    Box SJ; Corbett DF; Robins KG; Spear SR; Verrall MS
    J Antibiot (Tokyo); 1982 Oct; 35(10):1394-6. PubMed ID: 6983522
    [No Abstract]   [Full Text] [Related]  

  • 33. In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa.
    McLaughlin JC; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; Pfaller MA
    J Antimicrob Chemother; 1994 Feb; 33(2):223-30. PubMed ID: 8182003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutual pro-drugs of beta-lactam antibiotics and beta-lactamase inhibitors.
    Baltzer B; Binderup E; von Daehne W; Godtfredsen WO; Hansen K; Nielsen B; Sørensen H; Vangedal S
    J Antibiot (Tokyo); 1980 Oct; 33(10):1183-92. PubMed ID: 6969724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carpetimycins A and B, new beta-lactam antibiotics.
    Nakayama M; Iwasaki A; Kimura S; Mizoguchi T; Tanabe S; Murakami A; Watanabe I; Okuchi M; Itoh H; Saino Y; Kobayashi F; Mori T
    J Antibiot (Tokyo); 1980 Nov; 33(11):1388-90. PubMed ID: 7251479
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of beta-lactamase of Streptomyces cacaoi. I. Clavulanic acid and PS-5.
    Ogawara H; Mantoku A
    J Antibiot (Tokyo); 1981 Oct; 34(10):1341-6. PubMed ID: 6975771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorocardicin, a monocyclic beta-lactam from a Streptomyces sp. I. Discovery, production and biological activities.
    Nisbet LJ; Mehta RJ; Oh Y; Pan CH; Phelen CG; Polansky MJ; Shearer MC; Giovenella AJ; Grappel SF
    J Antibiot (Tokyo); 1985 Feb; 38(2):133-8. PubMed ID: 3922933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of BRL 42715, a beta-lactamase-inhibiting penem.
    Qadri SM; Ueno Y; Burdette M; Kroschinsky R; Almodovar E
    Chemotherapy; 1991; 37(6):398-404. PubMed ID: 1760938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?
    Devi P; Rutledge PJ
    Chembiochem; 2017 Feb; 18(4):338-351. PubMed ID: 27992105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.